Key facts
- This page summarizes Fred E. Cohen's Form 4 filing for CareDx, Inc. (CDNA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Jun 2022, 17:10.
Fred E. Cohen - 16 Jun 2022 Form 4 Insider Report for CareDx, Inc. (CDNA)
- Reporting relationship
- Director
- Issuer ticker
- CDNA
- Reported as of
- 16 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Jun 2022, 17:10:38 UTC
- Prior SEC filing
- 16 Jun 2022
- Next SEC filing
- 04 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Reginald Seeto, as attorney-in-fact for Fred E. Cohen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Fred E. Cohen filed Form 4 for CareDx, Inc. (CDNA) on 21 Jun 2022.
Change
- Previous filing in this sequence was filed on 16 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDNA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,863
- Change %
- +4.5%
- Price
- $0.000000
- Shares after
- 111,883
- Date
- 16 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDNA
transaction
Derivative
Common Stock
Award
- Transaction value
- $0
- Shares
- +7,606
- Change %
- Price
- $0.000000
- Shares after
- 7,606
- Date
- 16 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,606
- Exercise price
- $20.56
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reported securities are represented by restricted stock units which shall vest on June 16, 2023.
Footnote F2
1/12th of the shares subject to the option shall vest on July 16, 2022 and the shares subject to the option shall vest monthly thereafter through June 16, 2023.
SEC remarks
Exhibit 24 - Power of Attorney